Modulation of cardiac contractility through endothelin-1 release and myocardial mast cell degranulation

Eszlári, E. and Czóbel, M. and Molnár, G. and Bogáts, G. and Kaszaki, J. and Nagy, S. and Boros, M. (2008) Modulation of cardiac contractility through endothelin-1 release and myocardial mast cell degranulation. Acta Physiologica Hungarica, 95 (3). pp. 267-285. ISSN 0231-424X

Text aphysiol.95.2008.3.3.pdf Restricted to Repository staff only until 30 September 2028. Download (282kB)

Abstract

The aim of this study was to outline the consequences of a hypertonic saline-dextran-40 (HSD) infusion-induced peripheral flow stimulus on the ventricular function in closed-chest, pentobarbital-anesthetized dogs. We hypothesized that HSD-induced elevation in endothelin-1 (ET-1) and nitric oxide (NO) release can have a role in myocardial contractile responses; and that cardiac mast cells (MC) degranulation may be involved in this process. The consequences of disodium cromoglycate (a MC stabilizer) or ETR-p1/fl peptide (an endothelin-A receptor antagonist) treatment were evaluated. A 4 ml/kg iv HSD40 infusion significantly increased cardiac index and myocardial contractility, and resulted in a decreased peripheral resistance. The postinfusion period was characterized by significant plasma NO and ET-1 elevations, these hemodynamic and biochemical changes being accompanied by a decreased myocardial ET-1 content, NO synthase activity and enhanced myocardial MC degranulation. Disodium cromoglycate treatment inhibited the HSD40-induced elevations in myocardial contractility and MC degranulation, and similar hemodynamic changes were noted after treatment with ETR-p1/fl peptide, together with a normalized myocardial myocardial ET-1 content, NO synthesis and a significant reduction in MC degranulation. These results indicate that peripheral NO and ET-1 release modulates the cardiac contractility through myocardial ET-A receptor activation and MC degranulation.

Actions (login required)

Edit Item